)
Visual
test
Episurf Medical
Episurf Medical (EPIS) investor relations material
Episurf Medical Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary6 Feb, 2026
Executive summary
Achieved significant transformation in 2025, including the acquisition of real estate assets to create a new income-generating business segment alongside the medical device business.
Fourth quarter saw increased order intake and revenue, with a 13% rise in gross order intake to SEK 3.5m and net sales of SEK 3.5m.
Full-year gross order intake grew to SEK 14.8m (up from SEK 13.0m), with net sales at SEK 13.5m (up from SEK 13.0m).
U.S. market showed strong momentum, with a 65% increase in gross order intake and a 120% increase in customer base year-over-year.
Workforce reduced by 30% during the year, contributing to lower operating costs.
Financial highlights
Q4 2025 net sales: SEK 3.5m (Q4 2024: SEK 3.4m); full-year 2025 net sales: SEK 13.5m (2024: SEK 13.0m).
Q4 2025 loss for the period: SEK -13.5m (Q4 2024: SEK -18.1m); full-year 2025 loss: SEK -58.2m (2024: SEK -76.0m).
Earnings per share for Q4: SEK -0.01 (Q4 2024: SEK -0.03); full-year: SEK -0.06 (2024: SEK -0.16).
Cash and cash equivalents at year-end: SEK 7.1m (2024: SEK 50.5m).
Equity ratio at year-end: 79.3% (2024: 85.7%).
Outlook and guidance
Focus for 2026 is on expanding commercialisation in the U.S. and Europe, supporting distributors, and preparing for the launch of the Episealer® MTP implant pending FDA clearance.
Real estate segment expected to provide stable income to support medical device operations.
Real estate segment's expected financing support
Episealer MTP FDA: specific remaining hurdles
Plan to secure 12-month financing need?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebJOUT
Net sales up 31%, gross margin at 36.6%, and net loss narrowed to $3.3 million. - 6 FebPECO
Record 2025 occupancy and 7% Core FFO growth; 2026 targets 5.5% FFO growth and strong acquisitions. - 6 FebPROV
Q2 FY2026 net income rose 65% year-over-year, with higher margins and strong credit quality. - 6 FebNVDA
AI-driven digital twins and accelerated computing are set to revolutionize industrial design and manufacturing. - 6 FebCDP
2025 FFO/share rose 5.8% to $2.72, with strong leasing and investment; 2026 guidance signals more growth. - 6 FebCRI
Q1 2025 saw record revenue, a return to profit, and major new contracts in space technology. - 6 FebCRINet loss widened to 7.5m PLN in H1 2024 as revenue fell and R&D costs remained high.
- 6 FebCRINet loss deepened on lower sales and higher costs, but major new contracts and restructuring are underway.
- 6 FebEMBASSY
Record revenue, NOI, and distributions highlight strong growth and robust segment performance. - 6 FebCRIRevenue fell and losses deepened, but ESA contracts and R&D projects drive future prospects.
Next Episurf Medical earnings date
Q1 202624 Apr, 2026
Episurf Medical
Next Episurf Medical earnings date
Q1 202624 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Episurf Medical AB, a medical device company, designs and manufactures implants and surgical instruments. The company offers polyurethane foam products, including foam for sinus augmentation and reconstruction, as well as foam for other uses. It also provides polyurethane foam instruments for the delivery of bone morphogenetic protein product for orthopedic applications. In addition, the company is engaged in the research and development of new products targeting at cervical spine applications. The company is based in Stockholm, Sweden.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage